Abstract

This IDC study is the third of a three-part life science R&D IDC MarketScape series focused on IT outsourcing. With a specific focus on life science R&D ITO, this document seeks to compare major IT service providers with each other, based on operational, business, and market-centric criteria that should be important to life science companies when considering the selection of an external service provider to take over noncore IT activities. IDC MarketScape assessment of IT outsourcing in life science R&D was previously performed in 2011, 2013, 2015, and 2018.

Dr. Nimita Limaye, research VP, Life Science R&D Strategy and Technology at IDC, noted, "The COVID-19 pandemic has brought to the fore the importance of the ITO service providers to the life science industry. Their role has transitioned beyond that of serving as tactical providers to that of strategic partners that will help steer the implementation of agile innovation models, drive digital resiliency, and fuel accelerated business growth. It is for the ITO service providers to build their internal capabilities, strengthen their digital ecosystems, and provide both the technology and the mindshare that will help them truly leverage this momentous opportunity."

Coverage